Drugs / EMLA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06913855 | Apr → Jul 2025 | — | Istanbul Medeniyet University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EMLA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06913855 ↗ |
| Known as | EMLA cream | “Patients were randomly assigned to receive either morphine (0.1 mg/kg up to 10 mg IV 30 min before CTR) or EMLA cream (5 g per chest tube cutaneously 3 h before CTR).” PMID 10781447 ↗ May 2000 |
| Route | Topical | “EMLA cream (5 g per chest tube cutaneously 3 h before CTR)” PMID 10781447 ↗ May 2000 |